fda drug safety communication semaglutide naion 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" Huge recall of Glaucoma and

The fine structure of secretion by Plasmodium knowlesi merozoites during red cell invasion

Macrophage fatty acid oxidation in atherosclerosis

The need for informed consent was waived owing to the retrospective nature of this study, and the study design was approved by the Institutional Review Board of Pusan National University Hospital, Busan, Korea (No

Looking to the Future Despite the estimated 20% prevalence of MCAS in the general population, there are currently no MCAS-focused clinical trials for GLP-1 receptor agonists

Studies in mice with CNS neuron-specific GLP-1R knockout showed that liraglutide failed to induce weight loss but still improved glucose levels, suggesting that brain GLP-1Rs are necessary for the weight-lowering effect of GLP-1RAs but not essential for their glucose-lowering effects (142)

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs